Skip to Main Content
Home Books Current Medical Diagnosis & Treatment 2021

38-10: Antidotes

Craig Smollin; Kent R. Olson

Give an antidote (if available) when there is reasonable certainty of a specific diagnosis (Table 38–3). Be aware that some antidotes themselves may have serious side effects. The indications and dosages for specific antidotes are discussed in the respective sections for specific toxins.

Table 38–3.Some toxic agents for which there are specific antidotes.1
View Table|Favorite Table|Download (.pdf)
Table 38–3. Some toxic agents for which there are specific antidotes.1

Toxic Agent

Specific Antidote

Acetaminophen

N-Acetylcysteine

Anticholinergics (eg, atropine)

Physostigmine

Anticholinesterases (eg, organophosphate pesticides)

Atropine and pralidoxime (2-PAM)

Benzodiazepines

Flumazenil (rarely used)2

Carbon monoxide

Oxygen (hyperbaric oxygen of uncertain benefit)

Cyanide

Sodium nitrite, sodium thiosulfate; hydroxocobalamin

Digitalis glycosides

Digoxin-specific Fab antibodies

Heavy metals (eg, lead, mercury, iron) and arsenic

Specific chelating agents

Isoniazid

Pyridoxine (vitamin B6)

Methanol, ethylene glycol

Ethanol (ethyl alcohol) or fomepizole (4-methylpyrazole)

Opioids

Naloxone, nalmefene

Snake venom

Specific antivenin

Sulfonylurea oral hypoglycemic drugs

Glucose, octreotide

1See text for indications and dosages.

2May induce seizures in patients with preexisting seizure disorder, benzodiazepine addiction, or concomitant tricyclic antidepressant or other convulsant overdose. If seizures occur, diazepam and other benzodiazepine anticonvulsants will not be effective. As with naloxone, the duration of action of flumazenil is short (2–3 hours) and resedation may occur, requiring repeated doses.

+
+
Dart  RC  et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2018 Mar;71(3):314–25.
[PubMed: 28669553]  
+
+
Dzeshka  MS  et al. Direct oral anticoagulant reversal: how, when and issues faced. Expert Rev Hematol. 2017 Nov;10(11):1005–22.
[PubMed: 28901221]  
+
+
Schwenk  M. Chemical warfare agents. Classes and targets. Toxicol Lett. 2018 Sep 1;293:253–63.
[PubMed: 29197625]  

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MHE Privacy Center Close